Cerdulatinib (PRT2070)

Ref. 3D-YXB30079

Informations sur le produit

• Nom: Cerdulatinib (PRT2070)
• Marque: Biosynth
• Description: Cerdulatinib (PRT2070) is an ester hydrochloride compound with antifibrotic properties. It has been shown to inhibit the growth and proliferation of fibroblasts, which play a key role in the development of fibrosis. Cerdulatinib works by targeting alpha-tocotrienol, nintedanib, sildenafil, and other nucleophilic compounds involved in fibrotic pathways. Additionally, it has been found to inhibit fatty acid synthesis and collagen production, further contributing to its anti-fibrotic effects. Research suggests that cerdulatinib may also modulate the activity of β-catenin, a protein involved in cell signaling pathways related to fibrosis. This compound shows promise as a potential therapeutic option for various fibrotic conditions.

Propriétés chimiques

• Masse moléculaire: 445.54 g/mol
• Formule: C₂₀H₂₇N₇O₃S
• Degré de pureté: Min. 95%